Market Research Center Now Offering New Report : Global Cold Laser Therapy Market Forecast 2025–2032
The global cold laser therapy market is set to reach USD 187.1 million by 2032, driven by rising chronic pain cases, innovation, and home-use device adoption.
TOKYO, JAPAN, April 18, 2025 /EINPresswire.com/ -- The global cold laser therapy market is expected to reach USD 130.8 million by 2025 and grow at a CAGR of 5.2%, reaching USD 187.1 million by 2032.Growth is driven by the rising prevalence of chronic pain, musculoskeletal disorders, and sports injuries, along with increasing demand for non-invasive, drug-free treatment solutions.
The 2023 National Health Interview Survey (NHIS) reported that 24.3% of U.S. adults experience chronic pain, and 8.5% suffer from high-impact chronic pain limiting daily activities.
This widespread condition imposes an enormous economic burden, with related U.S. healthcare costs estimated between $565 billion and $635 billion annually, according to NCBI and PMC.
To address this, technological advancements such as multi-wavelength laser systems and home-use cold laser devices are improving treatment accessibility, affordability, and effectiveness.
Cold laser therapy, also known as low-level laser therapy (LLLT), is a non-invasive medical treatment that uses low-intensity laser light to stimulate healing. Unlike high-intensity surgical lasers, cold lasers do not generate heat or damage tissue. Instead, they promote cellular regeneration, reduce inflammation, and relieve pain by enhancing mitochondrial activity within cells. Commonly used for pain management, wound healing, and musculoskeletal therapy, cold laser therapy offers a drug-free, painless alternative for treating chronic conditions and acute injuries across a range of medical and rehabilitation settings.
Key Market Drivers
Growing Prevalence of Chronic Pain
Rising cases of chronic pain and musculoskeletal disorders are fueling the demand for non-invasive treatment alternatives like cold laser therapy.
Technological Innovations
Advances in continuous laser devices, portable handheld systems, and multi-wavelength technologies are expanding treatment options for clinical and consumer markets.
Consumer Shift to Home Therapies
The availability of FDA-cleared home-use devices, such as Erchonia’s EVRL and the iRestore laser, is promoting self-managed, convenient therapy options, thereby creating new revenue streams for manufacturers.
Market Challenges
While promising, cold laser therapy adoption faces significant competition from traditional treatment modalities such as:
Physical therapy
Ultrasound therapy
Shockwave therapy
Platelet-rich plasma (PRP) injections
These alternatives are often favored due to more extensive clinical validation, insurance reimbursement advantages, and established familiarity among healthcare professionals.
Key Opportunities
Expansion of Home-Use Devices
Increasing consumer preference for convenient, non-invasive therapy is driving robust growth of compact, handheld cold laser devices.
This trend broadens market accessibility beyond clinical environments and opens new opportunities in personal healthcare markets.
Market Insights
Product Type Trends
Continuous Laser Devices are forecasted to dominate the product segment by 2025, accounting for approximately 55.6% of the market.
Their steady energy delivery enables deep tissue penetration and precise dosage control, making them highly favored by healthcare professionals.
The FX 635 Laser from Erchonia Corporation, FDA-cleared for chronic low back and heel pain, exemplifies the advantages of continuous laser technology in reducing inflammation and stimulating cellular repair.
Modality Trends
Handheld Devices are projected to capture around 59.3% market share by 2025.
Their portability, ease of use, and ability to deliver localized treatments make them increasingly popular among both clinics and home users.
Devices such as the TerraQuant Pro by Multi Radiance Medical illustrate the strong demand for adaptable, user-friendly cold laser solutions.
Regional Market Overview
North America is anticipated to account for 43.3% of the global cold laser therapy market by 2025.
Growth is driven by:
Regulatory approvals (e.g., FDA clearance of Acclaro Corporation’s UltraClear™ system)
Increased clinical adoption in chronic pain management
Technological advancements in handheld and multi-wavelength laser systems
Europe is forecasted to secure 23.3% of market share by 2025.
Key factors include:
Enforcement of EU Medical Device Regulation (MDR), ensuring high safety and efficacy standards
Clinical validation of cold laser therapy for applications such as post-endodontic pain management
Strong adoption in physiotherapy clinics, sports medicine centers, and hospitals, particularly in Germany, France, and the U.K.
The East Asia market is expected to attain an 18.5% share, led by China and India.
Major developments include:
Formation of the Chinese Association for Laser in Medicine and Surgery (CALMS) in 2024
Innovation in Class 4 laser therapy technologies for pain relief and rehabilitation showcased at major medical exhibitions
Latin America is seeing growing adoption of cold laser therapy for applications such as:
Tissue regeneration
Mitochondrial energy production
Circulation improvement
Tinnitus treatment
Mexico, Brazil, and Argentina are leading the regional expansion, with research highlighting LLLT’s anti-inflammatory and regenerative benefits.
The cold laser therapy market is set for stable, consistent growth through 2032, driven by rising chronic pain management needs, technological advancements, and growing consumer acceptance of home-use devices.
While competition from traditional therapies remains, the advantages of cold laser therapy — including non-invasiveness, reduced inflammation, and enhanced tissue repair — position it as a critical solution in the future of pain management and rehabilitation worldwide.
[For more details about this report]
https://www.marketresearch.co.jp/reports/cold-laser-therapy-market/
[About Market Research Center]
Market Research Center Corporation is a global market research and consulting firm headquartered in Tokyo, Japan. Since its establishment in 2016, the company has been dedicated to providing high-quality market research reports and offering customized research services tailored to clients’ specific needs. Market Research Center supports a wide range of industries, including technology, healthcare, manufacturing, and consumer goods, serving listed companies, research institutions, and multinational enterprises worldwide. Leveraging a strong network of domestic and international research partners, the company delivers accurate, timely, and actionable insights to help organizations make informed strategic decisions. Market Research Center is committed to facilitating global business growth through reliable and comprehensive market intelligence.
• Company & Reports Sales Site --> https://www.marketresearch.co.jp
• Custom Research Service Site --> https://www.mrcenter.jp
Marketing & PR
Market Research Center Corporation
mrc@marketresearch.co.jp
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

HYDE SCHOOL LAUNCHES ADMISSIONS OUTREACH TRIP ACROSS THE NORTHEAST IN JUNE
Families Are Hungry, Shelves Are Bare: Charlotte Food Pantry Urgently Calls for Support
Eddie Dunn Appointed Interim President of VETS2INDUSTRY
Kalendarium
Więcej ważnych informacji
Jedynka Newserii

Jedynka Newserii

Polityka

PE przedstawił swoje priorytety budżetowe po 2027 roku. Wydatki na obronność kluczowe, ale nie kosztem polityki spójności
Parlament Europejski przegłosował w tym tygodniu rezolucję w sprawie priorytetów budżetu UE na lata 2028–2034. Europosłowie są zgodni co do tego, że obecny pułap wydatków w wysokości 1 proc. dochodu narodowego brutto UE-27 nie wystarczy do sprostania rosnącej liczbie wyzwań, przed którymi stoi Europa. Mowa między innymi o wojnie w Ukrainie, trudnych warunkach gospodarczych i społecznych oraz pogłębiającym się kryzysie klimatycznym. Eurodeputowani zwracają też uwagę na ogólnoświatową niestabilność, w tym wycofywanie się Stanów Zjednoczonych ze swojej globalnej roli.
Infrastruktura
Odbudowa Ukrainy pochłonie setki miliardów euro. Polskie firmy już teraz powinny szukać partnerów, nie tylko w kraju, ale i w samej Ukrainie

Według stanu na koniec 2024 roku odbudowa Ukrainy wymagać będzie zaangażowania ponad pół biliona euro, a Rosja wciąż powoduje kolejne straty. Najwięcej środków pochłoną sektory mieszkaniowy i transportowy, ale duże są także potrzeby energetyki, handlu czy przemysłu. Polski biznes wykazuje wysokie zaangażowanie w Ukrainie, jednak może ono być jeszcze wyższe w procesie odbudowy. Zdaniem wiceprezesa działającego w tym kraju Kredobanku należącego do Grupy PKO BP firmy powinny szukać partnerów do udziału w odbudowie i w Polsce, i w Ukrainie.
Polityka
Europoseł PiS zapowiada walkę o reparacje wojenne dla Polski na forum UE. Niemiecki rząd uznaje temat za zamknięty

Nowy kanclerz Niemiec Friedrich Merz podczas konferencji prasowej w Polsce ocenił, że temat reparacji wojennych w relacjach polsko-niemieckich jest prawnie zakończony. Nie zgadza się z tym europoseł PiS Arkadiusz Mularczyk, który chce do tego tematu wrócić na forum UE. Przygotowana za rządów PiS publikacja „Raport o stratach poniesionych przez Polskę w wyniku agresji i okupacji niemieckiej w czasie II wojny światowej” szacuje straty na ponad 6,2 bln zł.
Partner serwisu
Szkolenia

Akademia Newserii
Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.